Skip to main content
CPC 2023 Main banner

Full Schedule

  1. Home
  2. Full Schedule

Full Schedule

  • Saturday, October 7, 2023
  • 8:00 AM – 9:00 AM ET
    Breakfast
  • 8:45 AM – 8:50 AM ET
    Opening Remarks
  • 8:50 AM – 9:50 AM ET
    Session 8: Cancer Care at Home: Opportunities, Risks, and How to Prepare

    Moderator: John E. Hennessy, MBA – Valuate Health Consultancy

    Panelist: Aaron Gerber, MD, MBA – Reimagine Care, Inc.

    Panelist: Raj Hazarika, MD – Point32 Health

    Panelist: Barbara McAneny, MD – New Mexico Oncology Hematology Consultants & Former President AMA

    Panelist: Barry Russo, MBA – The Center for Cancer and Blood Disorders

    Panelist: Lindsey Zinck, PhD RN OCN NEA-BC – Univ Penn Medicine, Abramson Cancer Center

    • Learn about the current status of home-based cancer care • Consider the evolving business case, including the current value proposition, service limitations, and potential future opportunities
  • 9:50 AM – 10:50 AM ET
    Session 9: AI in Cancer Care: Separating Fact from Fiction

    Moderator: Ira Klein, MD, MBA – Tempus Labs

    Panelist: James Hamrick, MD – Flatiron Health

    Panelist: Ed Rodgers – ClinicalPath

    Panelist: Will Shapiro – Flatiron Health

    Panelist: Zachary Taft – Memorial Sloan Kettering Cancer Center

    Panelist: Amy Valley, PharmD – Cardinal Health Specialty Solutions

    • Understand the use case for AI in cancer care today, and study existing uses in oncology operations and care • Learn key principles for evaluating vendors and the legitimacy of AI-enabled technologies • Envision the future and how AI may significantly impact the delivery of care, including clinical pathways
  • 10:50 AM – 11:20 AM ET
    Break
  • 11:20 AM – 12:20 PM ET
    Session 10: Reimagining Clinical Trials in the Community Setting

    Moderator: Nina Chavez, MBA – Flatiron Health

    Panelist: Ivy Altomare, MD – Flatiron Health

    Panelist: Sibel Blau, MD – Northwest Medical Specialties / QCCA Network / Exigent Research

    Panelist: Lindsay Kehoe, MS, CGC – Duke University/Clinical Trial Transformation Initiative (CTTI)

    Panelist: Seo Yoon, MPH – Memorial Sloan Kettering Cancer Center

    • The current state of clinical research in community oncology • Increasing the reach and access of clinical trials into the community • How technologies and new models are changing clinical research
  • 12:20 PM – 12:50 PM ET
    Session 11: New Dimensions in Comprehensive Genomic Testing

    Moderator: Alan J. Balch, PhD – Patient Advocate Foundation

    Presenter: Eric Severson, MD, PhD, MMSc – Labcorp Oncology

    As genetics takes a greater role in the treatment of a wide spectrum of cancers, this session will examine genomic testing’s role in comprehensive oncology pathways.
  • 1:00 PM – 2:15 PM ET
    Non-Accredited Featured Partner Showcase
  • 2:20 PM – 3:05 PM ET
    Session 12: Utility of Clinical Pathways for Multiple Myeloma: Navigating Updates in Guidelines and Care

    Moderator: Frederick M. Schnell, MD, FACP – National Cancer Treatment Alliance/Community Oncology Alliance

    Presenter: Prashant Kapoor, MD – Mayo Clinic

  • 3:05 PM – 3:35 PM ET
    Exhibit Hall
  • 3:35 PM – 4:55 PM ET
    Session 13: Scaling Precision Medicine Expertise for Equitable Cancer Care: Breaking Barriers, Advancing Patient Outcomes

    Moderator: Ivy Altomare, MD – Flatiron Health

    Panelist: Debyani Chakravarty, PhD – Memorial Sloan Kettering Cancer Center

    Panelist: James Hamrick, MD – Flatiron Health

    Panelist: John W. Sweetenham, MD, FACP, FRCP, FASCO – UT Southwestern Simmons Comprehensive Cancer Center

    Precision medicine has revolutionized cancer care, but ensuring widespread access and high-quality implementation across the care continuum remains a challenge. In this session, we will explore strategies to scale precision medicine expertise, addressing barriers and highlighting resources to deliver personalized care to all patients.
  • 4:55 PM – 5:40 PM ET
    Session 14: Evidence-Based Approaches to Clinical Pathway Development for Metastatic Urothelial Cancer

    Moderator: Wui-Jin Koh, MD – National Comprehensive Cancer Network

    Presenter: Stephanie A. Berg, DO – Dana-Farber Cancer Institute , Lank Center for Genitourinary Oncology

  • 5:40 PM – 6:30 PM ET
    Exhibit Hall Reception